Medicare Advantage Premiums Fall in 2027. Will Yours Actually Drop?

A soft jobs report cooled rate-hike fears. All three indices rose. Nvidia touched a new high.

The quick scan: Friday's September jobs report came in well short of forecasts – just 29,000 jobs added, with unemployment ticking up to 4.2% from 4.1%. Traders pared back bets on another Fed hike in October, and all three indices closed higher, with tech out in front. Oil eased after G7 nations agreed to release 100 million barrels of oil and fuel from emergency reserves.

S&P 500: +0.73% to 7,722.72 – broad gains as rate-hike odds faded; Tesla jumped more than 5% after third-quarter deliveries beat analyst estimates
Dow Jones: +0.49% to 51,176.96 – added about 250 points; Cisco and Caterpillar led, while Nike fell after a weak full-year outlook
NASDAQ: +1.19% to 27,190.86 – the day's leader; Nvidia touched a new all-time intraday high, while Seagate and Western Digital slumped on reports Toshiba will double its hard-drive capacity.

What's driving it: This was a market listening to the Fed, not to the jobs data itself. With the Middle East war keeping energy prices high, investors have spent weeks bracing for more tightening. A weak payrolls number and slower wage growth – average hourly earnings up 3.0% on the year – gave the Fed room to wait, and the odds of an October hike fell sharply. Treasury yields dipped after the report, then climbed back, with the 10-year finishing near 5.28%, close to the multidecade highs it touched on Thursday. Brent still ended near $102 a barrel despite the G7 release. The Nasdaq ended the week higher; the Dow did not.

Bottom line: Yields near multidecade highs and oil above $100 are a reminder that the cost of living is not easing quickly. For L-Plate Retirees, the practical response to a high-cost world is to check the costs you can actually control.

Medicare Premiums Are Falling 16.5%. So Why Might Yours Go Up?

The scoop: There is an old joke about the statistician who drowned crossing a river that was, on average, three feet deep.

It is a useful joke to keep in mind this month, because the 2027 Medicare plan numbers have just landed. The headline is cheerful: the average Medicare Advantage premium is projected to fall 16.5% next year. The fine print, as fine print tends to be, is more interesting. Some people will pay less. Some will pay more. The average cannot tell you which group you are in.

With open enrollment running from 15 October to 7 December 2026, this is the month to find out.

The headline number

On 28 September, CMS – the federal agency that runs Medicare – released its first look at the 2027 plans. Across all Medicare Advantage plans, the weighted average monthly premium is projected to fall from $14.37 in 2026 to $12.00 in 2027.

The number of Medicare Advantage plans is roughly flat, edging from 5,553 to about 5,532. Roughly 8 in 10 Medicare Advantage enrollees will be able to keep their current plan at the same or a lower premium. Ninety-seven percent of people on Medicare will have access to 10 or more Medicare Advantage plans, and more than 99% to at least one. Supplemental benefits such as hearing, dental and vision are expected to remain stable.

If you are in Medicare Advantage, that is mostly good news. But 8 in 10 is not 10 in 10. The remaining two in ten will either pay more to stay where they are or need to choose again.

The number that went the other way

Stand-alone Part D drug plans – the kind many people pair with Original Medicare – tell a different story. The average total monthly premium is projected to rise from $35.09 to $36.00. Less than a dollar. Hardly worth a headline.

Except for, again, the fine print. These plans have been cushioned by a temporary subsidy called the Part D Premium Stabilization Demonstration. It was set up in 2024 to steady premiums while the Inflation Reduction Act's Part D redesign capped what enrollees pay out of pocket and shifted more of the cost onto the plans. In 2025, it knocked $15 off the base premium and capped year-on-year increases at $35. In 2026, that became a $10 reduction and a $50 cap. The two years cost $9.8 billion. The demonstration ends after 2026.

CMS describes the 2027 result as a return to normal market conditions. KFF, a health policy research group, warned before the release that without the subsidy, some stand-alone drug plan enrollees could face larger increases than they have seen in recent years. The average barely moved. Your plan might have.

Why the two drug-coverage prices sit so far apart

For Medicare Advantage plans that include drug coverage, the average Part D premium after rebates is projected to fall 38%, from $11.32 to $7.00. That leaves the $36 stand-alone average at roughly five times the Medicare Advantage figure.

KFF attributes that gap partly to the way Medicare Advantage plans can use rebates to buy down their drug premiums. It is a structural difference in how the two types of coverage are funded, not a verdict on which one suits you better. A premium is the price of the ticket, not the whole cost of the trip.

Stand-alone shoppers who look have options. Among beneficiaries who do not receive Extra Help – the Part D Low-Income Subsidy – 88% will have access to a basic stand-alone plan costing $10.30 a month or less, and 93% to an enhanced plan for under $6. Cheap options exist. They just do not come and find you.

What an average cannot tell you

This average blends every kind of Medicare Advantage plan, including those with drug coverage and Special Needs Plans. It says nothing about the plans in your county, the medicines in your cabinet, or the pharmacy you actually use.

AJMC makes the point plainly: because the CMS figures are averages, they do not show how premiums will change for individual plans. And KFF expects cost pressure to continue, from rising drug prices and growing use of GLP-1 drugs and other specialty medicines.

So the 16.5% fall is real. It is also somebody else's number until you check it against your own.

The calendar that matters

Plan comparison for 2027 opened on Medicare.gov on 1 October. The 2027 Star Ratings are due on or around 8 October. Open enrollment runs from 15 October to 7 December 2026, and new coverage starts on 1 January 2027.

If your current coverage still fits, you do not need to re-enrol. Doing nothing is a valid choice. It just should not be an accidental one.

The tools cost nothing: the Medicare.gov Plan Finder, or 1-800-MEDICARE if you would rather talk to a person. One more figure from the CMS fact sheets to pay attention to: only about half of the people eligible for the Medicare Savings Programs, which help with Medicare costs, are actually enrolled. If money is tight, that alone justifies a phone call.

The statistician's lesson

None of this calls for alarm. Most Medicare Advantage enrollees will see the same or a lower premium. The system, on average, looks stable.

But nobody lives on average. We live in one county, with one set of prescriptions, one budget and one plan. The river may be three feet deep on average. The only depth that matters is the spot where you are standing. An hour with the Plan Finder before 7 December is a cheap way to measure it.

This is general information, not personal advice.

Actionable takeaways for L-Plate Retirees:

• Treat the 16.5% as a national average, not a forecast for your plan. The projected fall from $14.37 to $12.00 blends every Medicare Advantage plan in the country, Special Needs Plans included. Roughly 8 in 10 enrollees can keep their plan at the same or lower premium, which means about 2 in 10 cannot. Find out which group you are in before you relax.

• If you have a stand-alone drug plan, check your 2027 premium line by line. The temporary subsidy that cushioned these premiums in 2025 and 2026 ends after this year. The average rises by less than a dollar, but KFF warned that some enrollees could see larger increases than in recent years. Your plan's figure is the one that counts.

• Compare coverage on total cost, not premium alone. The $7 average for Medicare Advantage drug coverage against $36 for stand-alone plans partly reflects how rebates are used, not which option is better for you. Enter your actual medicines and pharmacy into the Medicare.gov Plan Finder and compare what you would pay across the whole year.

• Put three dates in your diary. 2027 Star Ratings arrive on or around 8 October. Open enrollment runs 15 October to 7 December 2026. New coverage starts 1 January 2027.

• Make staying put a decision, not a default. You do not need to re-enrol if your current coverage still fits. That is a legitimate choice, but only after you have checked that next year's premium, drug list and pharmacy still suit you.

• Check whether you qualify for help. Only about half of the people eligible for the Medicare Savings Programs are enrolled, and 88% of people without Extra Help can find a basic stand-alone drug plan for $10.30 a month or less. If costs are stretching your budget, call 1-800-MEDICARE and ask.

Your Turn:
When your Medicare plan details for next year arrive, do you read them line by line, or skim for the premium and move on?
If your stand-alone drug plan premium rose by much more than the national average, would you switch plans or stay with what you know?
What is one cost in your retirement where you have been trusting a headline average instead of checking your own number?

👉 Hit reply and share your thoughts – your answers could inspire fellow readers in future issues.

☕If today's issue helped you see why a national Medicare average cannot tell you what your own plan will cost in 2027, consider supporting L-Plate Retiree on Ko-fi. Your support keeps these plain-English checks arriving before the deadlines, not after them.

Resources:

The Next Level Options (NLOMBA) course is a solid, all-in-one roadmap for mastering options investing. You’ll learn what options really are, how to invest in different market conditions, and how to pick strong companies using Buffett-inspired fundamentals.

Inside, the lessons walk you step-by-step through strategies like BOSS and Strategy X, so you’re not guessing – you’re following a proven structure that helps you invest with clarity and confidence.

What to see everything that’s included?
👉 Check out the Options Workshop